Previous 10 | Next 10 |
Today, we take an in-depth name at a small oncology concern named Molecular Templates. It has been busy few months for the firm as it is dealing with an FDA clinical hold, did a secondary offering, and announced an important new partnership. A full investment analysis follows in t...
Molecular Templates (MTEM): Q4 GAAP EPS of -$0.57 misses by $0.14.Revenue of $3.5M (-43.5% Y/Y) misses by $2.45M.As of December 31, 2020, MTEM’s cash and investments totaled $93.9 million. With the addition of the $70 million upfront payment from Bristol Myers Squibb received in 1Q21 a...
AUSTIN, Texas, March 18, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, e...
AUSTIN, Texas, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s proprietary engineered toxin...
Molecular Templates (MTEM) traded 2.7% down premarket after commencing an underwritten public offering; underwriters granted 30-day option to purchase up to an additional 15% of the shares.Offers size, terms have not yet been disclosed.Proceeds along with cash and equivalents t...
AUSTIN, Texas, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s proprietary engineered toxin...
Molecular Templates (MTEM) enters into a worldwide strategic research collaboration with Bristol Myers Squibb to discover and develop multiple novel therapies designed for specific oncology targets.The collaboration will seek to discover new molecules utilizing MTEM’s next generat...
AC Immune SA (ACIU) +112% as its vaccine generates potent anti-pTau antibody response in a phase 1b/2a study.RCM Technologies, Inc. (RCMT) +92%.Sundial Growers Inc. (SNDL) +48%.MicroVision, Inc. (MVIS) +44% after long range lidar update.Monopar Therapeutics (MNPR) +41% on poten...
AUSTIN, Texas, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM; “Molecular Templates” or “MTEM”) today announced that it has entered into a worldwide strategic research collaboration with Bristol Myers Squibb to discover and develop mult...
The FDA signs off Molecular Templates' ([[MTEM]] +5.5%) Investigational New Drug application for MT-6402, ETB targeting PD-L1 that is enabled with MTEM’s antigen seeding technology, that allows a dual mechanisms of action that include the enzymatic destruction of ribosomes and the deli...
News, Short Squeeze, Breakout and More Instantly...
Molecular Templates Inc. Company Name:
MTEM Stock Symbol:
NASDAQ Market:
Molecular Templates Inc. Website:
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineere...